Wasn't there another situation where they were about to be awarded a contract, and then the client got acquired and they lost it to FNZ too? I have the feeling this is the second time it has happened.
To put this in scale, Nucleus have around 17bn GBP in assets under management. Bravura supports clients for a total value of 1.6trn GBP. So it's around 1.1% of assets, not material in the long run but still a kick in the guts. Also they will continue using Bravura in the short term at least, so won't be felt for a little while.
Definitely not with -7% of the share price, but it seems we just can't break away from the $2.90s. At least we're not setting lower lows ($2.85 would do that).
BVS Price at posting:
$2.99 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)